Regenerative therapy for cardiomyopathies

Zi Wang, Xuan Su, Muhammad Ashraf, Il Man Kim, Neal L. Weintraub, Meng Jiang, Yaoliang Tang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Despite substantial advances in the development of medical and interventional strategies in ischemic and non-ischemic heart diseases, cardiovascular diseases (CVDs) remain the leading cause of mortality and morbidity worldwide. Stem cell therapy for heart disease has gained traction over the past two decades and is an emerging option for the treatment of myocardial dysfunction. In this review, we summarize the current literature on different types of stem cells and their potential usage in ischemic and non-ischemic heart diseases. We emphasize the clinical utility of stem cells to improve myocardial structural and function, promote microvascular angiogenesis, and diminish scar size and major adverse cardiovascular events.We also discuss the therapeutic potential of microvesicles, such as exosomes, in the treatment of CVDs, which may open novel avenues for further clinical studies.

Original languageEnglish (US)
Pages (from-to)357-365
Number of pages9
JournalJournal of Cardiovascular Translational Research
Volume11
Issue number5
DOIs
StatePublished - Jan 1 2018

Fingerprint

Cardiomyopathies
Heart Diseases
Stem Cells
Cardiovascular Diseases
Exosomes
Traction
Cell- and Tissue-Based Therapy
Cicatrix
Therapeutics
Morbidity
Mortality

Keywords

  • Angiogenesis
  • Exosomes
  • Ischemic heart diseases
  • Microvesicles
  • Non-ischemic heart diseases
  • Stem cells

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmaceutical Science
  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)

Cite this

Regenerative therapy for cardiomyopathies. / Wang, Zi; Su, Xuan; Ashraf, Muhammad; Kim, Il Man; Weintraub, Neal L.; Jiang, Meng; Tang, Yaoliang.

In: Journal of Cardiovascular Translational Research, Vol. 11, No. 5, 01.01.2018, p. 357-365.

Research output: Contribution to journalArticle

@article{d69a0c6b623b4c1fa2480ee5cfbd154a,
title = "Regenerative therapy for cardiomyopathies",
abstract = "Despite substantial advances in the development of medical and interventional strategies in ischemic and non-ischemic heart diseases, cardiovascular diseases (CVDs) remain the leading cause of mortality and morbidity worldwide. Stem cell therapy for heart disease has gained traction over the past two decades and is an emerging option for the treatment of myocardial dysfunction. In this review, we summarize the current literature on different types of stem cells and their potential usage in ischemic and non-ischemic heart diseases. We emphasize the clinical utility of stem cells to improve myocardial structural and function, promote microvascular angiogenesis, and diminish scar size and major adverse cardiovascular events.We also discuss the therapeutic potential of microvesicles, such as exosomes, in the treatment of CVDs, which may open novel avenues for further clinical studies.",
keywords = "Angiogenesis, Exosomes, Ischemic heart diseases, Microvesicles, Non-ischemic heart diseases, Stem cells",
author = "Zi Wang and Xuan Su and Muhammad Ashraf and Kim, {Il Man} and Weintraub, {Neal L.} and Meng Jiang and Yaoliang Tang",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s12265-018-9807-z",
language = "English (US)",
volume = "11",
pages = "357--365",
journal = "Journal of Cardiovascular Translational Research",
issn = "1937-5387",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Regenerative therapy for cardiomyopathies

AU - Wang, Zi

AU - Su, Xuan

AU - Ashraf, Muhammad

AU - Kim, Il Man

AU - Weintraub, Neal L.

AU - Jiang, Meng

AU - Tang, Yaoliang

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Despite substantial advances in the development of medical and interventional strategies in ischemic and non-ischemic heart diseases, cardiovascular diseases (CVDs) remain the leading cause of mortality and morbidity worldwide. Stem cell therapy for heart disease has gained traction over the past two decades and is an emerging option for the treatment of myocardial dysfunction. In this review, we summarize the current literature on different types of stem cells and their potential usage in ischemic and non-ischemic heart diseases. We emphasize the clinical utility of stem cells to improve myocardial structural and function, promote microvascular angiogenesis, and diminish scar size and major adverse cardiovascular events.We also discuss the therapeutic potential of microvesicles, such as exosomes, in the treatment of CVDs, which may open novel avenues for further clinical studies.

AB - Despite substantial advances in the development of medical and interventional strategies in ischemic and non-ischemic heart diseases, cardiovascular diseases (CVDs) remain the leading cause of mortality and morbidity worldwide. Stem cell therapy for heart disease has gained traction over the past two decades and is an emerging option for the treatment of myocardial dysfunction. In this review, we summarize the current literature on different types of stem cells and their potential usage in ischemic and non-ischemic heart diseases. We emphasize the clinical utility of stem cells to improve myocardial structural and function, promote microvascular angiogenesis, and diminish scar size and major adverse cardiovascular events.We also discuss the therapeutic potential of microvesicles, such as exosomes, in the treatment of CVDs, which may open novel avenues for further clinical studies.

KW - Angiogenesis

KW - Exosomes

KW - Ischemic heart diseases

KW - Microvesicles

KW - Non-ischemic heart diseases

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=85046657925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046657925&partnerID=8YFLogxK

U2 - 10.1007/s12265-018-9807-z

DO - 10.1007/s12265-018-9807-z

M3 - Article

C2 - 29744805

AN - SCOPUS:85046657925

VL - 11

SP - 357

EP - 365

JO - Journal of Cardiovascular Translational Research

JF - Journal of Cardiovascular Translational Research

SN - 1937-5387

IS - 5

ER -